Apotea AB (publ)STU:V30 +0.74%18 Gross Margin % is 28.33% as of Mar. 2026, which is 7% above its 10-year median of 26.58. GuruFocus rates STU:V30 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 629 Healthcare Providers & Services companies, Apotea AB (publ) ranks worse than 70.75% on this metric.
The historical rank and industry rank for Apotea AB (publ)'s Gross Margin % or its related term are showing as below:
STU:V30'
s Gross Margin % Range Over the Past 10 Years
Min: 26.04 Med: 26.58 Max: 27.34
Current: 27.07
During the past 5 years, the highestGross Margin % of Apotea AB (publ) was 27.34%. The lowest was 26.04%. And the median was 26.58%.
STU:V30's Gross Margin % is ranked worse than 70.75% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.06
vs STU:V30: 27.07
Apotea AB (publ) had a gross margin of 28.33% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Apotea AB (publ) was 0.00% per year.
Apotea AB (publ) (STU:V30) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Apotea AB (publ) had a gross margin of 28.33% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Apotea AB (publ) Gross Margin % Related Terms
Apotea AB (publ) Gross Margin % Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) Gross Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Gross Margin % distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Apotea AB (publ) (STU:V30) has a Gross Margin % of 28.33% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Apotea AB (publ) and its competitors. This is near median its historical median of 26.58. Over the past decade, Apotea AB (publ)'s Gross Margin % has ranged from 26.04 to 27.34. According to the industry distribution chart, Apotea AB (publ) ranks #445 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 70.7%.
Is Apotea AB (publ)'s Gross Margin % too high?
Apotea AB (publ)'s current Gross Margin % of 28.33% is near median its 10-year median of 26.58. Over the past 10 years, this metric has ranged from a low of 26.04 to a high of 27.34. The Healthcare Providers & Services industry median Gross Margin % is 40.06. Apotea AB (publ)'s value of 28.33% is 29.3% below this industry median. Based on the distribution chart, Apotea AB (publ) ranks #445 out of 629 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #445 out of 629 companies for Gross Margin %. This places Apotea AB (publ) in the lower half of its industry. The industry median Gross Margin % is 40.06. Apotea AB (publ)'s value of 28.33% is 29.3% below this benchmark. Historically, Apotea AB (publ)'s own Gross Margin % has ranged from 26.04 to 27.34 over the past decade. While the company's 10-year median is 26.58 vs. the industry median of 40.06, Apotea AB (publ) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.06, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current Gross Margin % of 28.33% is 29.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current Gross Margin % is 28.33%, which is near median its own 10-year median of 26.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (STU:V30) has a current Gross Margin % of 28.33%. The current Gross Margin % is 28.33%, which is near median its 10-year median of 26.58 and 29.3% below the Healthcare Providers & Services industry median of 40.06. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Apotea AB (publ) (STU:V30), the current Gross Margin % is 28.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for STU:V30
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:V30 has been successfully added to your 
